IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)
$29.52 -1.94 (-6.1666%)
Analysed IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) News Sources
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
19-04-2026
yahoo.com
Immunocore Details KIMMTRAK Growth, TCR Platform and Key Readouts at Needham Conference
14-04-2026
marketbeat.com
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
06-04-2026
yahoo.com
A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns
28-03-2026
yahoo.com
Jefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price Target
25-03-2026
yahoo.com
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
17-03-2026
yahoo.com
Qualcomm, Adobe downgraded: Wall Street's top analyst calls
16-03-2026
yahoo.com
Immunocore to present at upcoming investor conferences
03-03-2026
yahoo.com
Is It Time To Revisit Immunocore Holdings (IMCR) After Recent Pipeline Progress?
01-03-2026
yahoo.com
Immunocore Q4 Earnings Call Highlights
25-02-2026
marketbeat.com
What is the current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is $29.52.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is $-1.94.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is -6.1666%.
What is the most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.